These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
657 related articles for article (PubMed ID: 17564345)
21. Unexplained delayed nerve impairment in leprosy after treatment. Rosenberg NR; Faber WR; Vermeulen M Lepr Rev; 2003 Dec; 74(4):357-65. PubMed ID: 14750581 [TBL] [Abstract][Full Text] [Related]
22. Sural nerve biopsy in leprosy patients after varying periods of treatment: histopathological and bacteriological findings on light microscopy. Haimanot RT; Mshana RN; McDougall AC; Andersen JG Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):163-70. PubMed ID: 6539309 [TBL] [Abstract][Full Text] [Related]
23. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions. Legendre DP; Muzny CA; Swiatlo E Pharmacotherapy; 2012 Jan; 32(1):27-37. PubMed ID: 22392826 [TBL] [Abstract][Full Text] [Related]
24. The clinical and immunological features of leprosy. Walker SL; Lockwood DN Br Med Bull; 2006; 77-78():103-21. PubMed ID: 17090777 [TBL] [Abstract][Full Text] [Related]
30. Leprosy type 1 (reversal) reactions and their management. Walker SL; Lockwood DN Lepr Rev; 2008 Dec; 79(4):372-86. PubMed ID: 19274984 [TBL] [Abstract][Full Text] [Related]
31. Early diagnosis and treatment of leprosy in the United States. Style A Am Fam Physician; 1995 Jul; 52(1):172-8. PubMed ID: 7604761 [TBL] [Abstract][Full Text] [Related]
33. [Leprosy. Classification--clinical aspects--diagnosis--therapy]. Stingl P Z Hautkr; 1982 Nov; 57(21):1559-67. PubMed ID: 7148071 [TBL] [Abstract][Full Text] [Related]
34. Advances in the diagnosis and treatment of leprosy. Katoch VM Expert Rev Mol Med; 2002 Jul; 4(15):1-14. PubMed ID: 14585155 [TBL] [Abstract][Full Text] [Related]
35. Challenges presented by nerve damage in leprosy. Harboe M; Aseffa A; Leekassa R Lepr Rev; 2005 Mar; 76(1):5-13. PubMed ID: 15881032 [TBL] [Abstract][Full Text] [Related]
36. The imperatives of leprosy treatment in the pre- and post-global leprosy elimination era: appraisal of changing the scenario to current status. Sehgal VN; Sardana K; Dogra S J Dermatolog Treat; 2008; 19(2):82-91. PubMed ID: 17852638 [TBL] [Abstract][Full Text] [Related]
37. Histopathological and clinical findings in leprosy patients with chronic neuropathic pain: a study from Hyderabad, India. Lund C; Koskinen M; Suneetha S; Lockwood DN; Haanpää M; Haapasalo H; Hietaharju A Lepr Rev; 2007 Dec; 78(4):369-80. PubMed ID: 18309711 [TBL] [Abstract][Full Text] [Related]
38. Neuritic leprosy: further progression and significance. Mishra B; Mukherjee A; Girdhar A; Husain S; Malaviya GN; Girdhar BK Acta Leprol; 1995; 9(4):187-94. PubMed ID: 8711979 [TBL] [Abstract][Full Text] [Related]
39. Unknown presentations of pure neuritic leprosy. Narahari SR Indian J Lepr; 1997; 69(4):401-6. PubMed ID: 9474517 [No Abstract] [Full Text] [Related]
40. [Leprosy: a rare imported disease]. Gain M; Ghnaya H; Lepeytre F; Toledano C; Cabane J; Phong Tiev K Rev Med Interne; 2009 Dec; 30(12):1064-6. PubMed ID: 19836114 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]